FdaApplication
BLA 761069
Identifiers
- fda_app_no: BLA761069
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca UK Ltd |
| application_type | BLA |
| approval_date | 2017-05-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMFINZI | DURVALUMAB | 500MG/10ML (50MG/ML) | Injection |
| IMFINZI | — | 120MG/2.4ML (50MG/ML) | Injection |
2 products